These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8545030)
1. Sorivudine: a promising drug for the treatment of varicella-zoster virus infection. Whitley RJ Neurology; 1995 Dec; 45(12 Suppl 8):S73-5. PubMed ID: 8545030 [TBL] [Abstract][Full Text] [Related]
2. Sorivudine: a potent inhibitor of varicella zoster virus replication. Whitley RJ Adv Exp Med Biol; 1996; 394():41-4. PubMed ID: 8815706 [TBL] [Abstract][Full Text] [Related]
3. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group. Gnann JW; Crumpacker CS; Lalezari JP; Smith JA; Tyring SK; Baum KF; Borucki MJ; Joseph WP; Mertz GJ; Steigbigel RT; Cloud GA; Soong SJ; Sherrill LC; DeHertogh DA; Whitley RJ Antimicrob Agents Chemother; 1998 May; 42(5):1139-45. PubMed ID: 9593141 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults. The Multinational Sorivudine Study Group. Bodsworth NJ; Boag F; Burdge D; Généreux M; Borleffs JC; Evans BA; Modai J; Colebunders R; Thomas M; DeHertogh D; Pacelli L; Thomis J J Infect Dis; 1997 Jul; 176(1):103-11. PubMed ID: 9207355 [TBL] [Abstract][Full Text] [Related]
5. The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster. Yan J; Tyring SK; McCrary MM; Lee PC; Haworth S; Raymond R; Olsen SJ; Diasio RB Clin Pharmacol Ther; 1997 May; 61(5):563-73. PubMed ID: 9164418 [TBL] [Abstract][Full Text] [Related]
6. New antivirals with activity against varicella-zoster virus. Gnann JW Ann Neurol; 1994; 35 Suppl():S69-72. PubMed ID: 8185303 [TBL] [Abstract][Full Text] [Related]
7. Antiviral therapy of herpes simplex and varicella-zoster virus infections. Wutzler P Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639 [TBL] [Abstract][Full Text] [Related]
8. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. Okuda H; Ogura K; Kato A; Takubo H; Watabe T J Pharmacol Exp Ther; 1998 Nov; 287(2):791-9. PubMed ID: 9808711 [TBL] [Abstract][Full Text] [Related]
10. Treatment of progressive outer retinal necrosis with sorivudine. Pinnolis MK; Foxworthy D; Kemp B Am J Ophthalmol; 1995 Apr; 119(4):516-7. PubMed ID: 7709980 [TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of acyclovir versus netivudine for treatment of herpes zoster. International Zoster Study Group. Söltz-Szöts J; Tyring S; Andersen PL; Lucht RF; McKendrick MW; Diaz Perez JL; Shukla S; Fiddian AP J Antimicrob Chemother; 1998 May; 41(5):549-56. PubMed ID: 9630408 [TBL] [Abstract][Full Text] [Related]
12. Sorivudine and 5-fluorouracil; a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase. Diasio RB Br J Clin Pharmacol; 1998 Jul; 46(1):1-4. PubMed ID: 9690942 [TBL] [Abstract][Full Text] [Related]
13. Strategic proposals for predicting drug-drug interactions during new drug development: based on sixteen deaths caused by interactions of the new antiviral sorivudine with 5-fluorouracil prodrugs. Watabe T J Toxicol Sci; 1996 Dec; 21(5):299-300. PubMed ID: 9035040 [No Abstract] [Full Text] [Related]
14. Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil. Nakayama H; Kinouchi T; Kataoka K; Akimoto S; Matsuda Y; Ohnishi Y Pharmacogenetics; 1997 Feb; 7(1):35-43. PubMed ID: 9110360 [TBL] [Abstract][Full Text] [Related]
15. [Lethal drug interactions of the new antiviral, sorivudine, with anticancer prodrugs of 5-fluorouracil]. Watabe T; Okuda H; Ogura K Yakugaku Zasshi; 1997 Nov; 117(10-11):910-21. PubMed ID: 9414600 [TBL] [Abstract][Full Text] [Related]
16. Sorivudine (BV-ara-U) for the treatment of complicated refractory varicella zoster virus infection in HIV-infected patients. Burdge DR; Voigt R; Lindley JI; Gage L; Sacks SL AIDS; 1995 Jul; 9(7):810-2. PubMed ID: 7546429 [No Abstract] [Full Text] [Related]
17. Drug susceptibilities of isolates of varicella-zoster virus in a clinical study of oral brovavir. Machida H; Nishitani M Microbiol Immunol; 1990; 34(4):407-11. PubMed ID: 2163486 [TBL] [Abstract][Full Text] [Related]
18. Outer retinal necrosis due to a strain of varicella-zoster virus resistant to acyclovir, ganciclovir, and sorivudine. Wunderli W; Miner R; Wintsch J; von Gunten S; Hirsch HH; Hirschel B Clin Infect Dis; 1996 May; 22(5):864-5. PubMed ID: 8722954 [No Abstract] [Full Text] [Related]
19. Recognition and treatment of shingles. Nikkels AF; Piérard GE Drugs; 1994 Oct; 48(4):528-48. PubMed ID: 7528128 [TBL] [Abstract][Full Text] [Related]
20. Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. Okuda H; Nishiyama T; Ogura K; Nagayama S; Ikeda K; Yamaguchi S; Nakamura Y; Kawaguchi K; Watabe T; Ogura Y Drug Metab Dispos; 1997 Feb; 25(2):270-3. PubMed ID: 9029059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]